These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35435639)

  • 1. Efficacy and Safety of Tramadol Hydrochloride Twice-Daily Sustained-Release Bilayer Tablets with an Immediate-Release Component for Chronic Pain Associated with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study.
    Kawai S; Sobajima S; Jinnouchi M; Nakano H; Ohtani H; Sakata M; Adachi T
    Clin Drug Investig; 2022 May; 42(5):403-416. PubMed ID: 35435639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of twice-daily tramadol hydrochloride bilayer sustained-release tablets with an immediate release component for postherpetic neuralgia: Results of a Phase III, randomized, double-blind, placebo-controlled, treatment-withdrawal study.
    Kawai S; Hasegawa J; Ito H; Fukuuchi Y; Nakano H; Ohtani H; Sasaki K; Adachi T
    Pain Pract; 2023 Mar; 23(3):277-289. PubMed ID: 36478501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator.
    Shinkai M; Katsumata N; Kawai S; Kuyama S; Sasaki O; Yanagita Y; Yoshida M; Uneda S; Tsuji Y; Harada H; Nishida Y; Sakamoto Y; Himeji D; Arioka H; Sato K; Katsuki R; Shomura H; Nakano H; Ohtani H; Sasaki K; Adachi T
    Support Care Cancer; 2023 Dec; 32(1):69. PubMed ID: 38157081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Lee JH; Lee CS;
    Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Gana TJ; Pascual ML; Fleming RR; Schein JR; Janagap CC; Xiang J; Vorsanger GJ;
    Curr Med Res Opin; 2006 Jul; 22(7):1391-401. PubMed ID: 16834838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee.
    Babul N; Noveck R; Chipman H; Roth SH; Gana T; Albert K
    J Pain Symptom Manage; 2004 Jul; 28(1):59-71. PubMed ID: 15223085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
    DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
    Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain.
    Choi CB; Song JS; Kang YM; Suh CH; Lee J; Choe JY; Lee CK; Shim SC; Chung WT; Song GG; Kim HA; Ji JD; Nam EJ; Park SH; Hong YH; Sheen DH; Lim MK; Seo YI; Sung YK; Kim TH; Lee JT; Bae SC
    Clin Ther; 2007 Jul; 29(7):1381-9. PubMed ID: 17825689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tramadol extended-release tablets.
    Hair PI; Curran MP; Keam SJ
    Drugs; 2006; 66(15):2017-27; discussion 2028-30. PubMed ID: 17100415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD).
    Fishman RL; Kistler CJ; Ellerbusch MT; Aparicio RT; Swami SS; Shirley ME; Jain AK; Fortier L; Robertson S; Bouchard S
    J Opioid Manag; 2007; 3(5):273-80. PubMed ID: 18181382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis.
    Burch F; Fishman R; Messina N; Corser B; Radulescu F; Sarbu A; Craciun-Nicodin MM; Chiriac R; Beaulieu A; Rodrigues J; Beignot-Devalmont P; Duplan A; Robertson S; Fortier L; Bouchard S
    J Pain Symptom Manage; 2007 Sep; 34(3):328-38. PubMed ID: 17583466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study.
    Ruoff GE; Rosenthal N; Jordan D; Karim R; Kamin M;
    Clin Ther; 2003 Apr; 25(4):1123-41. PubMed ID: 12809961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
    Vorsanger G; Xiang J; Jordan D; Farrell J
    Clin Ther; 2007; 29 Suppl():2520-35. PubMed ID: 18164919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
    Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW
    Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
    Emkey R; Rosenthal N; Wu SC; Jordan D; Kamin M;
    J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with pain due to osteoarthritis: the efficacy and safety of a once-daily formulation of tramadol.
    Kean WF; Bouchard S; Roderich Gossen E
    Pain Med; 2009 Sep; 10(6):1001-11. PubMed ID: 19671089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study to compare the efficacy and safety of extended-release and immediate-release tramadol HCl/acetaminophen in patients with acute pain following total knee replacement.
    Park YB; Ha CW; Cho SD; Lee MC; Lee JH; Seo SS; Kang SB; Kyung HS; Choi CH; Chang N; Rhim HY; Bin SI
    Curr Med Res Opin; 2015 Jan; 31(1):75-84. PubMed ID: 25299350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.